Status:

RECRUITING

Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization

Lead Sponsor:

Takeshi Morimoto

Conditions:

Stable Angina Pectoris

Coronary Artery Disease

Eligibility:

All Genders

20+ years

Phase:

PHASE4

Brief Summary

The purpose of this study is to evaluate the efficacy and safety aspirin in patients with chronic coronary syndromes without revascularization.

Detailed Description

Aspirin for secondary prevention in the acute phase of acute coronary syndromes has been established. Although it is still disputable about the duration, there is also a consensus for antiplatelet the...

Eligibility Criteria

Inclusion

  • Patients with chronic coronary syndromes with ≧50% diameter stenosis in one or more major coronary vessels/major branches on coronary CT or coronary angiography but not eligible for coronary revascularization
  • Patients for whom consent can be obtained

Exclusion

  • Patients with history of acute coronary syndromes (ACS)
  • Patients with history of percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG)
  • Patients with left main trunk stenosis (≥50%)
  • Patients for whom aspirin administration is mandatory
  • Patients undergoing antithrombotic therapy other than aspirin
  • Patients with atrial fibrillation
  • Patients with history of stroke within six months
  • Patients scheduled for major surgical procedures that will require aspirin discontinuation
  • Patients with contraindication of aspirin
  • Patients expected to have a prognosis of 1 year or less due to comorbidities
  • Women of child-bearing potential or women who have a positive pregnancy test at enrolment or randomization
  • Patients who are judged by attending physicians to be inappropriate to participate in this study

Key Trial Info

Start Date :

June 14 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2030

Estimated Enrollment :

2890 Patients enrolled

Trial Details

Trial ID

NCT05347069

Start Date

June 14 2022

End Date

December 1 2030

Last Update

March 11 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Kyoto University Hospital

Kyoto, Japan

Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization | DecenTrialz